HomeCRNX • NASDAQ
add
Crinetics Pharmaceuticals Inc
$29.96
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$29.96
Sarado: Hun 27, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$29.99
Sakop ng araw
$29.59 - $30.85
Sakop ng taon
$24.10 - $62.53
Market cap
2.81B USD
Average na Volume
685.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 361.00K | -43.59% |
Gastos sa pagpapatakbo | 35.53M | 70.57% |
Net na kita | -96.77M | -44.59% |
Net profit margin | -26.81K | -156.34% |
Kita sa bawat share | -1.04 | -11.83% |
EBITDA | -110.48M | -51.23% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.27B | 41.42% |
Kabuuang asset | 1.36B | 39.17% |
Kabuuang sagutin | 107.33M | 3.98% |
Kabuuang equity | 1.25B | — |
Natitirang share | 93.68M | — |
Presyo para makapag-book | 2.24 | — |
Return on assets | -19.92% | — |
Return on capital | -20.77% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -96.77M | -44.59% |
Cash mula sa mga operasyon | -88.45M | -67.35% |
Cash mula sa pag-invest | -85.96M | -27,919.09% |
Cash mula sa financing | 4.44M | -98.87% |
Net change in cash | -169.98M | -149.84% |
Malayang cash flow | -47.18M | -69.57% |
Tungkol
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018. Wikipedia
Itinatag
Nob 18, 2008
Website
Mga Empleyado
437
